215 related articles for article (PubMed ID: 21816823)
21. Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons.
Patel CA; Mukhtar M; Harley S; Kulkosky J; Pomerantz RJ
J Neurovirol; 2002 Apr; 8(2):86-99. PubMed ID: 11935461
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.
Ferrucci A; Nonnemacher MR; Wigdahl B
Adv Virus Res; 2011; 81():165-99. PubMed ID: 22094081
[TBL] [Abstract][Full Text] [Related]
23. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
Na H; Acharjee S; Jones G; Vivithanaporn P; Noorbakhsh F; McFarlane N; Maingat F; Ballanyi K; Pardo CA; Cohen EA; Power C
Retrovirology; 2011 Jun; 8():44. PubMed ID: 21645334
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.
Mamik MK; Hui E; Branton WG; McKenzie BA; Chisholm J; Cohen EA; Power C
J Neuroimmune Pharmacol; 2017 Jun; 12(2):233-248. PubMed ID: 27726055
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 Vpr increases Env expression by preventing Env from endoplasmic reticulum-associated protein degradation (ERAD).
Zhang X; Zhou T; Frabutt DA; Zheng YH
Virology; 2016 Sep; 496():194-202. PubMed ID: 27343732
[TBL] [Abstract][Full Text] [Related]
26. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.
Langevin C; Maidou-Peindara P; Aas PA; Jacquot G; Otterlei M; Slupphaug G; Benichou S
J Virol; 2009 Oct; 83(19):10256-63. PubMed ID: 19625402
[TBL] [Abstract][Full Text] [Related]
28. HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication.
Peng M; Xiao X; He Y; Jiang Y; Zhang M; Peng F; Tian Y; Xu Y; Gong G
J Gen Virol; 2015 Aug; 96(8):2453-2463. PubMed ID: 25920531
[TBL] [Abstract][Full Text] [Related]
29. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
[TBL] [Abstract][Full Text] [Related]
30. Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection.
Höhne K; Businger R; van Nuffel A; Bolduan S; Koppensteiner H; Baeyens A; Vermeire J; Malatinkova E; Verhasselt B; Schindler M
Open Biol; 2016 Jul; 6(7):. PubMed ID: 27383627
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain.
Acharjee S; Noorbakhsh F; Stemkowski PL; Olechowski C; Cohen EA; Ballanyi K; Kerr B; Pardo C; Smith PA; Power C
FASEB J; 2010 Nov; 24(11):4343-53. PubMed ID: 20628092
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.
Vivithanaporn P; Maingat F; Lin LT; Na H; Richardson CD; Agrawal B; Cohen EA; Jhamandas JH; Power C
PLoS One; 2010 Sep; 5(9):e12856. PubMed ID: 20877724
[TBL] [Abstract][Full Text] [Related]
33. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.
Lubow J; Virgilio MC; Merlino M; Collins DR; Mashiba M; Peterson BG; Lukic Z; Painter MM; Gomez-Rivera F; Terry V; Zimmerman G; Collins KL
Elife; 2020 Mar; 9():. PubMed ID: 32119644
[TBL] [Abstract][Full Text] [Related]
34. Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
James T; Nonnemacher MR; Wigdahl B; Krebs FC
J Neurovirol; 2016 Aug; 22(4):403-15. PubMed ID: 27056720
[TBL] [Abstract][Full Text] [Related]
35. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
36. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.
Deshmane SL; Mukerjee R; Fan S; Del Valle L; Michiels C; Sweet T; Rom I; Khalili K; Rappaport J; Amini S; Sawaya BE
J Biol Chem; 2009 Apr; 284(17):11364-73. PubMed ID: 19204000
[TBL] [Abstract][Full Text] [Related]
37. Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes.
Mishra S; Mishra JP; Kumar A
J Biol Chem; 2007 Feb; 282(7):4288-4301. PubMed ID: 17158886
[TBL] [Abstract][Full Text] [Related]
38. Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review.
Williams ME; Williams AA; Naudé PJW
BMC Infect Dis; 2023 Aug; 23(1):512. PubMed ID: 37545000
[TBL] [Abstract][Full Text] [Related]
39. Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB.
Lahti AL; Manninen A; Saksela K
Virology; 2003 May; 310(1):190-6. PubMed ID: 12788643
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
